Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,546 | -114,762 | -103,315 | -88,401 | -79,231 |
| Depreciation Amortization | 54 | 178 | 119 | 67 | 16 |
| Accounts payable and accrued liabilities | 321 | 922 | 118 | 587 | -409 |
| Other Working Capital | -2,643 | 1,680 | -689 | -2,249 | -3,646 |
| Other Operating Activity | 1,451 | 93,131 | 92,127 | 85,954 | 85,821 |
| Operating Cash Flow | $-11,363 | $-18,851 | $-11,640 | $-4,042 | $2,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -252 | -233 | -5 | N/A |
| Net Acquisitions | N/A | 17,143 | 17,143 | 17,143 | 17,143 |
| Purchase Sale Intangibles | N/A | -4,000 | -4,000 | N/A | N/A |
| Other Investing Activity | 0 | -4,000 | -4,000 | 0 | 0 |
| Investing Cash Flow | $N/A | $12,891 | $12,910 | $17,138 | $17,143 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -234 | N/A | N/A | N/A |
| Common Stock Issued | 8 | 62,659 | 62,624 | 62,536 | 62,398 |
| Financing Cash Flow | $8 | $62,425 | $62,624 | $62,536 | $62,398 |
| Beginning Cash Position | 103,554 | 47,089 | 47,089 | 47,089 | 47,089 |
| End Cash Position | 92,199 | 103,554 | 110,983 | 122,721 | 129,181 |
| Net Cash Flow | $-11,355 | $56,465 | $63,894 | $75,632 | $82,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,363 | -18,851 | -11,640 | -4,042 | 2,551 |
| Capital Expenditure | N/A | -252 | -233 | -5 | N/A |
| Free Cash Flow | -11,363 | -19,103 | -11,873 | -4,047 | 2,551 |